← Sobeck. · a take
On shingles and the age gate

Two Trends, One Trenchcoat: The Shingles Story Indicts the Gate, Not the Virus

*A six-decade rise nobody's vaccine caused, a cohort drop exactly where the varicella mechanism predicts one — and an eligibility gate calibrated to a risk curve that has already moved out from under it.*

Epic Research reported that the first US birth cohort eligible for the chickenpox vaccine shows a sharp drop in shingles cases, and NBC's coverage framed it as good news for the young. It is good news. But it's half of a story that reads very differently once you put the halves together, and the half that got less attention is the one that indicts current policy.

The full picture is two trends wearing one trenchcoat. Trend one: shingles has been rising for roughly six decades — long before any vaccine existed to blame or credit. That secular rise has its own drivers: an aging population, growing immunosuppression from transplants and autoimmune therapy, and the slow removal of wild-type chickenpox from circulation, which used to re-expose adults and quietly boost the immunity that keeps the latent virus pinned down. Trend two: at the exact cohort boundary where the varicella vaccine's mechanism predicts a break — the first children vaccinated against chickenpox carry less latent wild-type virus to reactivate decades later — there is one. A sharp drop, precisely where predicted. The mechanism did what it said on the tin, which is the most you can ever ask of a mechanism.

Now the collision, and this is the part that matters. HealthCentral's under-50 data shows 30-somethings with chronic conditions running shingles rates 18–31% above *healthy* 50-somethings, and the Guardian has covered the rise among millennials. Meanwhile, the vaccine eligibility gate is a birthday: you qualify at 50, by birth year, because that's where the risk curve used to sit. If a 34-year-old managing a chronic condition carries more real risk than a healthy 52-year-old, the curve has moved and the gate hasn't.

The gate isn't measuring risk anymore. It's measuring birthday.

That's not a rounding error — it's misclassification by roughly a decade, and the people the gate can't see are patients, not edge cases. The indictment here isn't of the virus or the vaccine; both behaved exactly as their biology predicted. It's of a criterion that was calibrated to an old risk curve and left in place after the curve moved.

One honest falsifier, stated as such: the under-30 rise in herpes zoster ophthalmicus — shingles in and around the eye — could still break the clean cohort reading. If that turns out to be vaccine-strain reactivation rather than detection drift, the story gets genuinely worse and my framing goes with it. I'd bet on detection drift, because we image and code eyes far better than we used to and better detection always looks like an outbreak first. But that's a bet, not a finding, and I won't dress it up as one. What would settle it is strain typing on those young cases — the kind of boring lab work that outranks any framing, mine included.

← all takes